MedTech

The Tesla of braces: EvoNexus Portfolio Company InBrace raises an additional $100 million in investment for invisible braces product

Read More

PacBio Acquires EvoNexus Portfolio Company Omniome for $800M

Read More

World’s First aprevo™ Personalized Spine Surgery Performed Using the Only Available Spine Technology with FDA Breakthrough Designation

Read More

Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million

Read More

Carlsmed Raises $10M to Commercialize Breakthrough aprevo™ Devices

Read More

Carlsmed aprevo™ Granted Unprecedented Decision by FDA

Read More

Zelegent and Cook Medical Meet Success with New FDA Clearance

Read More